The chemoresistance of human malignant melanoma: an update.
about
Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistanceStress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferationNon-toxic melanoma therapy by a novel tubulin-binding agentThe role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells.A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts.Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cellsSolamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway.Suppression of P-gp induced multiple drug resistance in a drug resistant gastric cancer cell line by overexpression of FasThe metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase.Genetics and epigenetics of melanoma.Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastasesCombined effects of GSTP1 and MRP1 in melanoma drug resistanceEnhanced cell killing by overexpression of dominant-negative phosphatidylinositol 3-kinase subunit, Deltap85, following genotoxic stresses.Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro.Hydrodynamic shear rate regulates melanoma-leukocyte aggregation, melanoma adhesion to the endothelium, and subsequent extravasationDemethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells.Squid ink polysaccharide prevents autophagy and oxidative stress affected by cyclophosphamide in Leydig cells of mice: a pilot study.
P2860
Q26778761-E3754FA1-5A3C-4745-8BF8-528E75E26A83Q28195631-AD1205A9-8B7D-4618-9E2F-33EBBD83CA35Q30491925-C3A3919A-4757-4A5C-AED6-86FBACF521E2Q30837718-F84F2370-20D3-47A0-A4AA-C0AFE67F2AFCQ35551957-F5523F20-2AAC-4EA3-9BFB-FC01E05CEACFQ35657923-1E2ADB4C-6746-46AB-B3AC-1D6837605624Q35926931-DF5C7709-D934-460C-B8B8-C3225E0B1CA7Q36397702-FA71E3F8-D18C-4990-94CB-469BC7B4DBB5Q36996450-9C9C2C86-ACC6-467D-9258-69327176D990Q37406812-9800453C-7801-4CFA-9322-17300C45DB17Q37421620-C3A65713-1B7F-44B0-8F41-E72F56F1AD13Q40401556-AD25DAE8-CE9A-4C8F-844A-BD6876153706Q40836382-2358E785-C600-4387-83C5-850A88B6DED5Q41988099-FEB8F95D-F42A-4F06-8046-075B8716F820Q41989625-C7BBDCC4-7AD0-46B7-B595-CA4B06B417FBQ42082506-EA9E345E-CF6D-4F02-9ABA-ABA04D6AC190Q47162016-DE2D8142-C569-4FF5-B10D-EDE2C5AB145DQ47165049-51E2AF5C-5EAA-43D4-AB69-724D004683F1
P2860
The chemoresistance of human malignant melanoma: an update.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The chemoresistance of human malignant melanoma: an update.
@ast
The chemoresistance of human malignant melanoma: an update.
@en
type
label
The chemoresistance of human malignant melanoma: an update.
@ast
The chemoresistance of human malignant melanoma: an update.
@en
prefLabel
The chemoresistance of human malignant melanoma: an update.
@ast
The chemoresistance of human malignant melanoma: an update.
@en
P1433
P1476
The chemoresistance of human malignant melanoma: an update
@en
P2093
P356
10.1097/00008390-199902000-00007
P407
P577
1999-02-01T00:00:00Z